Myomo, Inc. (MYO): Price and Financial Metrics

Myomo, Inc. (MYO): $0.53

0.02 (+4.76%)

POWR Rating

Component Grades













MYO Price/Volume Stats

Current price $0.53 52-week high $2.39
Prev. close $0.51 52-week low $0.37
Day low $0.51 Volume 329,600
Day high $0.57 Avg. volume 706,508
50-day MA $0.60 Dividend yield N/A
200-day MA $0.93 Market Cap 11.18M

MYO Stock Price Chart Interactive Chart >


  • MYO scores best on the Sentiment dimension, with a Sentiment rank ahead of 99.18% of US stocks.
  • The strongest trend for MYO is in Growth, which has been heading up over the past 98 days.
  • MYO's current lowest rank is in the Stability metric (where it is better than 9.1% of US stocks).

MYO Stock Summary

  • MYO has a higher market value than only 3.96% of US stocks; more precisely, its current market capitalization is $9,520,155.
  • With a year-over-year growth in debt of -48.49%, MYOMO INC's debt growth rate surpasses just 6.07% of about US stocks.
  • The volatility of MYOMO INC's share price is greater than that of 94.22% US stocks with at least 200 days of trading history.
  • If you're looking for stocks that are quantitatively similar to MYOMO INC, a group of peers worth examining would be BSQR, FTFT, PWFL, KNDI, and PMD.
  • MYO's SEC filings can be seen here. And to visit MYOMO INC's official web site, go to

MYO Valuation Summary

  • In comparison to the median Healthcare stock, MYO's EV/EBIT ratio is 100.83% lower, now standing at -0.1.
  • Over the past 72 months, MYO's price/earnings ratio has gone up 4.5.

Below are key valuation metrics over time for MYO.

Stock Date P/S P/B P/E EV/EBIT
MYO 2023-05-23 0.6 1.0 -0.9 -0.1
MYO 2023-05-22 0.6 0.9 -0.9 0.0
MYO 2023-05-19 0.6 1.0 -0.9 0.0
MYO 2023-05-18 0.6 1.0 -0.9 -0.1
MYO 2023-05-17 0.7 1.0 -0.9 -0.1
MYO 2023-05-16 0.7 1.1 -1.0 -0.1

MYO's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • MYO has a Quality Grade of D, ranking ahead of 5.17% of graded US stocks.
  • MYO's asset turnover comes in at 0.65 -- ranking 59th of 186 Medical Equipment stocks.
  • BDX, ATRI, and BTCY are the stocks whose asset turnover ratios are most correlated with MYO.

The table below shows MYO's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.650 0.696 -26.424
2021-03-31 0.559 0.674 -133.294
2020-12-31 0.516 0.657 78.522
2020-09-30 0.419 0.644 -102.361
2020-06-30 0.386 0.692 -74.662
2020-03-31 0.433 0.736 -76.097

Myomo, Inc. (MYO) Company Bio

Myomo, Inc. operates as a medical robotics company. The Company offers expanded mobility for those suffering from neurological disorders and upper-limb paralysis. Myomo develops and markets arm braces to restore function in the paralyzed and weakened arms and hands of individuals that have suffered a stroke, spinal cord, and nerve injury.

MYO Latest News Stream

Event/Time News Detail
Loading, please wait...

MYO Latest Social Stream

Loading social stream, please wait...

View Full MYO Social Stream

Latest MYO News From Around the Web

Below are the latest news stories about MYOMO INC that investors may wish to consider to help them evaluate MYO as an investment opportunity.

Here's Why Myomo, Inc. (MYO) Is a Great 'Buy the Bottom' Stock Now

Myomo, Inc. (MYO) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

Yahoo | May 22, 2023

Myomo, Inc. (MYO) Reports Q1 Loss, Tops Revenue Estimates

Myomo, Inc. (MYO) delivered earnings and revenue surprises of 26.67% and 3.51%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | May 10, 2023

Supernus Pharmaceuticals (SUPN) Q1 Earnings and Revenues Beat Estimates

Supernus (SUPN) delivered earnings and revenue surprises of 141.67% and 8.99%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | May 9, 2023

Owens & Minor (OMI) Beats Q1 Earnings and Revenue Estimates

Owens & Minor (OMI) delivered earnings and revenue surprises of 155.56% and 4.15%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | May 5, 2023

Myomo to Report First Quarter Financial Results on May 10, 2023

BOSTON, May 03, 2023--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the three months ended March 31, 2023 on May 10, 2023.

Yahoo | May 3, 2023

Read More 'MYO' Stories Here

MYO Price Returns

1-mo -10.18%
3-mo -18.34%
6-mo -13.00%
1-year -74.76%
3-year -85.98%
5-year -99.45%
YTD 3.64%
2022 -92.53%
2021 1.71%
2020 -25.42%
2019 -79.11%
2018 -61.60%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 1.0859 seconds.